Biolife Solutions Inc (BLFS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Biolife Solutions Inc   (NASDAQ: BLFS)
 

Biolife Solutions Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Biolife Solutions Inc 's inventory turnover ratio sequentially decreased to 1.24 in the second quarter 2026, unsurprisingly, as the Biolife Solutions Inc markets continue to deteriorate, and BLFS's faces growing challenges to bring down its inventories. Biolife Solutions Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 294 days, from 292 days, in the Mar 31 2026 quarter.

Within Healthcare sector 291 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1776, from total ranking in the first quarter 2026 at 1937.

BLFS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biolife Solutions Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLFS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 28.53 % 19.11 % 3.94 % -13.53 % -14.79 %
Y / Y Cost of Sales Growth 26.68 % 40.67 % 31.77 % 5.97 % -6.72 %
Inventory Turnover Ratio (TTM) 1.24 1.25 1.2 1.13 1.07
BLFS's Total Ranking # 1776 # 1937 # 1871 # 1878 # 1899
Average inventory processing period 295 293 304 323 341
Seq. Inventory Growth 8.4 % 8.88 % 8.37 % 0.49 % 0.45 %
Seq. Cost of Sales Growth 1.79 % 4.52 % 3.01 % 15.59 % 13.03 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 292
Overall Market # 1776

Inventory Turnover Ratio Statistics
High Average Low
15.33 3.05 1.05
(Mar 31 2014)   (Mar 31 2025)



BLFS Company Profile >> Back to BLFS Efficiency Comparisons >> Compare BLFS Inventory Turnover Ratio to its Competitors

Financial Statements
Biolife Solutions Inc 's Inventories $ 36 Millions Visit BLFS's Balance sheet
Biolife Solutions Inc 's Cost of Revenues TTM $ 39 Millions Visit BLFS's Income Statement
What are BLFS's Sales? Visit BLFS's Sales by Segment

Other Inventory Turnover Ratios
Biolife Solutions Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BLFS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BLFS's Competitors
Inventory Turnover Ratio for BLFS's Suppliers
Inventory Turnover Ratio for BLFS's Customers

You may also want to know
BLFS's Sales Growth Rates BLFS's Pe Price to earnings ratio BLFS's Receivables Turnover Ratio BLFS's Stock Quote
BLFS's Net Income Growth Rates BLFS's Ps Price to Sales ratio BLFS's Sales per Employee BLFS's Asset Turnover Ratio
BLFS's Net Margin BLFS's Pb Price to Book ratio BLFS's Financial Strength Ratios BLFS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions
Aquestive Therapeutics Inc   2.42 $ 17.828  Millions$ 7  Millions
Viatris Inc   2.41 $ 9,604.200  Millions$ 3,993  Millions
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
Tela Bio Inc   2.30 $ 26.348  Millions$ 11  Millions
Sanara Medtech Inc   2.29 $ 7.981  Millions$ 3  Millions
China Pharma Holdings Inc  2.25 $ 3.450  Millions$ 2  Millions
Beta Bionics Inc   2.23 $ 50.111  Millions$ 22  Millions
Medtronic Plc  2.21 $ 13,136.000  Millions$ 5,950  Millions

Date modified: 2026-09-05T14:58:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.